ArticlePlants (Basel, Switzerland)2022
Growth and Biosynthesis of Phenolic Compounds of Canola (
Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Characterizing the effect of short wavelengths on the floral flavonoid metabolome of medicinal cannabis using a comparative computational metabolomics workflow.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Enhanced physiological performance and induced genetic variation in radish (Raphanus sativus L.) under gamma irradiation via silver chromate/aluminum-organic framework application.BMC plant biology · 2026Article
- Enhancing the Quality of Indoor-Grown Basil Microgreens with Low-Dose UV-B or UV-C Light Supplementation.International journal of molecular sciences · 2025Article
- Light regulates the synthesis and accumulation of plant secondary metabolites.Frontiers in plant science · 2025Review
- Urban Flora Riches: Unraveling Metabolic Variation Along Altitudinal Gradients in Two Spontaneous Plant Species.Plants (Basel, Switzerland) · 2024Article
- The Multifaceted Responses of Plants to Visible and Ultraviolet Radiation.Plants (Basel, Switzerland) · 2024Article
- UV-B induced flavonoid accumulation and related gene expression in blue- grained wheat at different periods of time.Frontiers in plant science · 2024Article
- Molecular Shield for Protection of Buckwheat Plants from UV-B Radiation.Molecules (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The application of ultraviolet-B (UV-B) irradiation to supplement visible light as an elicitor to increase bioactive compounds under controlled conditions is increasing. This study aimed to evaluate the effects of UV-B dose and wavelength region (280−300 and 300−320 nm) on the morphological, physiological, and biochemical responses of canola plants (Brassica napus L.). Canola plants (17 days after sowing) were subjected to various UV-B intensities (i.e., 0.3, 0.6, and 0.9 W m−2) and were divided into cut and non-cut treatments for each UV treatment. Plant growth parameters exhibited different trends based on the treated UV irradiation intensity. Plant growth gradually decreased as the UV irradiation intensity and exposure time increased. Despite the same UV irradiation intensity, plant response varied significantly depending on the presence or absence of a short-wavelength cut filter (<300 nm). Canola plants suffered more leaf damage in nonfilter treatments containing shorter wavelengths (280−300 nm). UV treatment effectively activates the expression of secondary metabolite biosynthetic genes, differing depending on the UV irradiation intensity. Our results suggest that both UV irradiation intensity and wavelength should be considered when enhancing antioxidant phytochemicals without inhibiting plant growth in a plant factory with artificial light.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.